Literature DB >> 24905766

Peptidophospholipids: synthesis, phospholipase A2 catalyzed hydrolysis, and application to development of phospholipid prodrugs.

Renato Rosseto1, Joseph Hajdu2.   

Abstract

New phospholipid analogues incorporating sn-2-peptide substituents have been prepared to probe the fundamental structural requirements for phospholipase A2 catalyzed hydrolysis of PLA2-directed synthetic substrates. Two structurally different antiviral oligopeptides with C-terminal glycine were introduced separately at the sn-2-carboxylic ester position of phospholipids to assess the role of the α-methylene group adjacent to the ester carbonyl in allowing hydrolytic cleavage by the enzyme. The oligopeptide-carrying phospholipid derivatives were readily incorporated into mixed micelles consisting of natural phospholipid (dipalmitoyl phosphatidylcholine, DPPC) and Triton X-100 as surfactant. Hydrolytic cleavage of the synthetic peptidophospholipids by the phospholipase A2 occurred slower, but within the same order of magnitude as the natural substrate alone. The results provide useful information toward better understanding the mechanism of action of the enzyme, and to improve the design and synthesis of phospholipid prodrugs targeted at secretory PLA2 enzymes.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral prodrugs; Lipid-prodrug design; Phospholipase A(2) catalysis; Phospholipid synthesis

Mesh:

Substances:

Year:  2014        PMID: 24905766      PMCID: PMC4183669          DOI: 10.1016/j.chemphyslip.2014.06.001

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  27 in total

1.  Drug-phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A(2).

Authors:  M Kurz; G K Scriba
Journal:  Chem Phys Lipids       Date:  2000-10       Impact factor: 3.329

Review 2.  Fusion peptides and the mechanism of viral fusion.

Authors:  Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2003-07-11

Review 3.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

4.  Studies on phospholipase A and its zymogen from porcine pancreas. IV. The influence of chemical modification of the lecithin structure on substrate properties.

Authors:  P P Bonsen; G H de Haas; W A Pieterson; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1972-07-07

Review 5.  Emerging roles of secreted phospholipase A(2) enzymes: an update.

Authors:  Makoto Murakami; Gérard Lambeau
Journal:  Biochimie       Date:  2012-09-25       Impact factor: 4.079

Review 6.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 7.  Secreted phospholipase A2 revisited.

Authors:  Makoto Murakami; Yoshitaka Taketomi; Hiroyasu Sato; Kei Yamamoto
Journal:  J Biochem       Date:  2011-07-11       Impact factor: 3.387

8.  Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme.

Authors:  E Valentin; F Ghomashchi; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

Review 9.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  Structural requirements for the inhibition of membrane fusion by carbobenzoxy-D-Phe-Phe-Gly.

Authors:  R M Epand; R F Epand; C D Richardson; P L Yeagle
Journal:  Biochim Biophys Acta       Date:  1993-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.